This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pure Chemicals Co., Ltd.. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Maki Akemichi: Innovator in Quantitative Analysis
Introduction
Maki Akemichi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of quantitative analysis, particularly in the area of liver function testing. His innovative approach has led to the development of a reliable method for analyzing 3-oxo-5.beta.-steroids.
Latest Patents
Maki Akemichi holds 1 patent for his invention titled "Method and reagent for quantitative analysis of 3-oxo-5.beta.-steroid." This patent describes a method that involves acting on a sample with 3-oxo-5.beta.-steroid.DELTA..sup.4 -dehydrogenase in the presence of a reducing chromophoric agent. The optical density of the resulting chromophoric substance is then measured. A typical reducing chromophoric agent used in this process is a tetrazolium compound. This invention provides a simple and reliable method for conducting liver function tests.
Career Highlights
Maki Akemichi is associated with Daiichi Pure Chemicals Co., Ltd., where he has been able to apply his expertise in quantitative analysis. His work has been instrumental in advancing the methodologies used in biochemical testing.
Collaborations
Maki has collaborated with notable colleagues such as Senkichi Nagasaki and Takae Shigihara. Their combined efforts have contributed to the success of various projects within their field.
Conclusion
Maki Akemichi's innovative work in quantitative analysis has paved the way for advancements in liver function testing. His contributions are significant in the realm of medical diagnostics, showcasing the importance of innovation in healthcare.